Your browser doesn't support javascript.
loading
Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.
Goldenberg, Ronald M; Gilbert, Jeremy D; Hramiak, Irene M; Woo, Vincent C; Zinman, Bernard.
Afiliação
  • Goldenberg RM; LMC Diabetes and Endocrinology, Concord, Ontario, Canada.
  • Gilbert JD; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Hramiak IM; Division of Endocrinology and Metabolism, St Joseph's Health Care London, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Woo VC; Section of Endocrinology and Metabolism, Health Sciences Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Zinman B; Lunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Diabetes Obes Metab ; 21(10): 2192-2202, 2019 10.
Article em En | MEDLINE | ID: mdl-31183975
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article